Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Saved in:
| Title: | Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. |
|---|---|
| Authors: | Warrick JI; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA, USA., Hu W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yamashita H; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA, USA.; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA., Walter V; Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, USA., Shuman L; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA, USA.; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA., Craig JM; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA, USA.; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA., Gellert LL; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Castro MAA; Bioinformatics and Systems Biology Laboratory, Federal University of Parana, Curitiba, Paraná, Brazil., Robertson AG; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada., Kuo F; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ostrovnaya I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sarungbam J; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen YB; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gopalan A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sirintrapun SJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fine SW; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tickoo SK; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kim K; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Thomas J; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Karan N; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gao SP; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Clinton TN; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lenis AT; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chan TA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen Z; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rao M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hollman TJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Li Y; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Socci ND; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chavan S; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Viale A; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mohibullah N; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bochner BH; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pietzak EJ; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Teo MY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Iyer G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rosenberg JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Bajorin DF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kaag M; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA., Merrill SB; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA., Joshi M; Department of Medicine, Division of Hematology-Oncology, Penn State Cancer Institute, Hershey, PA, USA., Adam R; Department of Urology, Boston Children's Hospital, Boston, MA, USA., Taylor JA 3rd; Department of Urology, University of Kansas Medical Center, Kansas City, MO, USA., Clark PE; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Raman JD; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA., Reuter VE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chen Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Funt SA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Solit DB; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., DeGraff DJ; Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA, USA. ddegraff@pennstatehealth.psu.edu.; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA. ddegraff@pennstatehealth.psu.edu.; Deparment of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, USA. ddegraff@pennstatehealth.psu.edu., Al-Ahmadie HA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. alahmadh@mskcc.org. |
| Source: | Nature communications [Nat Commun] 2022 Dec 23; Vol. 13 (1), pp. 7920. Date of Electronic Publication: 2022 Dec 23. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-35644-0 |